Repici, A.; Capra, A.P.; Hasan, A.; Bulzomì, M.; Campolo, M.; Paterniti, I.; Esposito, E.; Ardizzone, A.
Novel Findings on CCR1 Receptor in CNS Disorders: A Pathogenic Marker Useful in Controlling Neuroimmune and Neuroinflammatory Mechanisms in Parkinson’s Disease. Int. J. Mol. Sci. 2024, 25, 4337.
https://doi.org/10.3390/ijms25084337
AMA Style
Repici A, Capra AP, Hasan A, Bulzomì M, Campolo M, Paterniti I, Esposito E, Ardizzone A.
Novel Findings on CCR1 Receptor in CNS Disorders: A Pathogenic Marker Useful in Controlling Neuroimmune and Neuroinflammatory Mechanisms in Parkinson’s Disease. International Journal of Molecular Sciences. 2024; 25(8):4337.
https://doi.org/10.3390/ijms25084337
Chicago/Turabian Style
Repici, Alberto, Anna Paola Capra, Ahmed Hasan, Maria Bulzomì, Michela Campolo, Irene Paterniti, Emanuela Esposito, and Alessio Ardizzone.
2024. "Novel Findings on CCR1 Receptor in CNS Disorders: A Pathogenic Marker Useful in Controlling Neuroimmune and Neuroinflammatory Mechanisms in Parkinson’s Disease" International Journal of Molecular Sciences 25, no. 8: 4337.
https://doi.org/10.3390/ijms25084337
APA Style
Repici, A., Capra, A. P., Hasan, A., Bulzomì, M., Campolo, M., Paterniti, I., Esposito, E., & Ardizzone, A.
(2024). Novel Findings on CCR1 Receptor in CNS Disorders: A Pathogenic Marker Useful in Controlling Neuroimmune and Neuroinflammatory Mechanisms in Parkinson’s Disease. International Journal of Molecular Sciences, 25(8), 4337.
https://doi.org/10.3390/ijms25084337
